RxDoctor Payments Data

Matthew Tingle, MD

Sports Medicine · Omaha, NENPI 1285086488

Payments from drug & device makers

What this record shows

This record is dominated by grants: $20,000 of the $32,022 with a category attached, or 62.5%. Arthrex accounts for 71.6% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $20,399 and has fallen 84.9% since, to $3,088 in 2025. Among sports medicine clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,022in general payments, 2019–2025

Across 115 payments — averaging $278.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$23K
  • Stryker$2K
  • Zimmer Biomet$2K
  • Encore Medical, LP$2K
  • Team 1, LLC$1K
  • Smith+Nephew$660
  • plus $2K from 14 others

What the payments were for

  • Grants$20,00062%
  • Travel & lodging$7,06222%
  • Food & beverage$4,83515%
  • Education$1250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,022 in reported general payments places this provider in the 90th percentile of 34 sports medicine providers in Nebraska.

See all sports medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$74,442
Medicare patients
145
Services billed
801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib29$590
Diclofenac Sodium13$440
Meloxicam96$333
Oxycodone Hcl50$296
Pregabalin24$282
Ondansetron Hcl32$118
Methylprednisolone20$103
Tizanidine Hcl27$80
Tramadol Hcl19$41

Paid to pharmacies, not to this prescriber.

Other sports medicine in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →